技术人员

技术人员

图片7.png

胡进静,实习研究员 hjjsina@126.com

中山大学 硕士毕业  (2013年)

复旦大学 进修学习  (2014年)

研究方向/领域:

肝癌侵袭和转移,表观遗传学;

擅长技术:(分子克隆、基因敲除、基因整合、细胞功能实验)、(Ai、PS、Primer、Graphpad、image)

已发表论文:

(1) JinJing Hu, Ming Tian, YongLong Guo, Wen-Bo Meng, Bing Bai, Zhong-Tian Bai, Jun Yan, Yong-Na Wu, Li-Ming Wang, Xia Hu, Li-Ping Yang , Xiao-Jun Liu , Ying Li and Xun Li(*), Cancer related fatigue and clinical outcome of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients., Journal of Immunooncology, 2016.2(1):1~6;

(2) Bai B, Lin Y, JinJing Hu, Wang H, Li L, Zhao S, Zhang J, Meng W, Yue P, Bai Z, Li X(*), Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients., Oncol Rep. 2019.41(10): 1539~1548;

(3) Shen HJ, JinJing Hu, Li XR, Liu JZ(*), Engineering of Escherichia coli for Lycopene Production Through Promoter Engineering., Curr Pharm Biotechnol., 2015.16(12):1094~103;

(4) Wang ZC, Liu LZ, Liu XY, JinJing Hu, Wu YN, Shi JY, Yang LX, Duan M, Wang XY, Zhou J, Fan J, Gao Q(*). Genetic polymorphisms of the multidrug resistance 1 gene MDR1 and the risk of hepatocellular carcinoma., Tumour Biol. 2015,36(9):7007~15

(5) Xun Li(*),Yongqiang Zhou, JinJing Hu,et al. Loss of neuropilin1 inhibits liver cancer stem cells population and blocks metastasis in hepatocellular carcinoma via epithelial-mesenchymal transition. NEOPLASMA.2020.

主持或参加科研项目(课题)情况

①“兰州大学中央高校”(lzujbky-2020-kb05):2020年7月-2021年10月,1万,主持人;